Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

WASHINGTON, DC, UNITED STATES, March 14, 2025 /EINPresswire.com/ -- At the American College of Radiation Oncology annual meeting in Las Vegas, Nevada, on March 14 ...

Eli Lilly stock has advanced more than 200% over the past three years thanks to the company’s dominance in the weight loss drug market. Lilly may face more competitors down the road in this high ...

All right. So, I think we should get started here. For those of you who don't know me, my name is Dave Risinger. I'm responsible for diversified biopharma research at Leerink Partners. It's very ...

March 10 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and Mexico in the second half of ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of ...

NEW MADRID — Lillian Nunnery was full of life. When she was happy, she was the happiest girl in the world, her family said. When she was sad or angry, everyone knew it. What they didn’t ...

Earlier this week, Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial Zepbound (tirzepatide) to patients in the virtual care companies ...

A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture knockoff versions of Eli Lilly's tirzepatide while a lawsuit plays out.

Michael Headrick says he’s lost 18 pounds since starting Zepbound injections about a month ago, with no noticeable side effects. (Photo courtesy of Adam Seif) Michael Headrick of Indianapolis ...